Overview
Niroshan Nadarajah practices practicing medicine in Munich, Germany.
Nadarajah is highly rated in 3 conditions, according to our data. Their clinical expertise encompasses Leukemia, Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML), and RUNX1 Familial Platelet Disorder.
They are actively involved in clinical research, co-authoring 51 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Niroshan Nadarajah
Is Niroshan Nadarajah a top-rated expert for Leukemia?
MediFind is an objective health platform that identifies experts based on real-world data. Niroshan Nadarajah is classified as an Distinguished expert for Leukemia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Niroshan Nadarajah participate in research or clinical trials?
Yes. Niroshan Nadarajah has published 51 articles and abstracts on conditions like Leukemia. You can view a list of Niroshan Nadarajah's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- LeukemiaNadarajah isDistinguished. Learn about Leukemia.
- Advanced
- Acute Myeloid Leukemia (AML)Nadarajah isAdvanced. Learn about Acute Myeloid Leukemia (AML).
- Myelodysplastic Syndrome (MDS)Nadarajah isAdvanced. Learn about Myelodysplastic Syndrome (MDS).
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Nadarajah isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Chronic B-Cell Leukemia (CBCL)Nadarajah isExperienced. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Lymphocytic Leukemia (CLL)Nadarajah isExperienced. Learn about Chronic Lymphocytic Leukemia (CLL).
- Chronic Myelogenous Leukemia (CML)Nadarajah isExperienced. Learn about Chronic Myelogenous Leukemia (CML).
- Chronic Myelomonocytic Leukemia (CMML)
- Essential ThrombocythemiaNadarajah isExperienced. Learn about Essential Thrombocythemia.
- LeukocytosisNadarajah isExperienced. Learn about Leukocytosis.
- Myeloproliferative Neoplasms (MPN)Nadarajah isExperienced. Learn about Myeloproliferative Neoplasms (MPN).
- Paroxysmal Cold HemoglobinuriaNadarajah isExperienced. Learn about Paroxysmal Cold Hemoglobinuria.
- Paroxysmal Nocturnal Hemoglobinuria (PNH)
- Philadelphia-Negative Chronic Myeloid Leukemia
- RUNX1 Familial Platelet DisorderNadarajah isExperienced. Learn about RUNX1 Familial Platelet Disorder.
- Small Lymphocytic Lymphoma (SLL)Nadarajah isExperienced. Learn about Small Lymphocytic Lymphoma (SLL).